Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Emblem Corp EMMBF

"Emblem Corp is a licensed producer of medical cannabis. It is intended to cultivate and cure cannabis for medicinal use. The group operates in the business segment of production and sale of medical cannabis."

OTCPK:EMMBF - Post Discussion

Emblem Corp > Unbelievable
View:
Post by Dcoyote on Dec 19, 2018 11:52am

Unbelievable

To sell a company when the whole sector is at its most undervalued is dumb dumb. Bad bad timing. Emblem could of gotten a way better deal than that for the shareholders. Look what Aurora paid for acquisitions. We got ripped ripped off. That saying the merger is good but that is all it is. Two companies joining togeather we gain nothing we loose nothing as a shareholder.
Comment by KingWhaleSucks1 on Dec 19, 2018 12:26pm
May not see the benefits right away but the increase in operating clinics means increased profit and increased share value. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities